UMU logo

News

Two Nordic foundations support a network in Cryo-EM, a Nobel Prize–winning technology

Jacques Dubochet, Nobel Laureate in Chemistry 2017, visited the cryo-EM Facility at UCEM on 13 December 2017, together UCEM-Director Linda Sandblad and Lars-Anders Carlson, researcher at WCMM.A new Swedish-Danish research alliance wants to advance understanding of how biological molecules look and behave. With support from the Knut and Alice Wallenberg Foundation and the Novo Nordisk Foundation, scientists at four universities in Sweden and Denmark will join forces to create a Nordic network in cryoelectron microscopy, whose developers were awarded the 2017 Nobel Prize in Chemistry.

The CryoNet network will bring together experts in cryoelectron microscopy at universities in Aarhus, Copenhagen, Stockholm and Umeå. A Swedish- Danish partnership between the Knut and Alice Wallenberg Foundation and the Novo Nordisk Foundation will fund the network. Each foundation has awarded a grant of €1 million over 4 years for CryoNet.

Read more: Two Nordic foundations support a network in Cryo-EM, a Nobel Prize–winning technology

1st Arctic Meeting on Clinical Tuberculosis, Umeå 25-26 January, 2018

Artic Tbc Conference 25 26 JanWelcome to the Arctic Meeting on Clinical Tuberculosis, Umeå!
The first Arctic Meeting on Clinical Tuberculosis will take place at Norrland University Hospital and is organized by researchers at Umeå University, Infection Clinic / TB Centrum Norr and TBnet.

Registration (deadline 20 January 2018)
Registration form

Please visit ucmr.umu.se for preliminary programme.

Nobel Laureate Jacques Dubochet visits Umeå University

19645 Nobelbesok 960x342 32

NCMM Director to join Institute for Cancer Research at Oslo University

57 Kjetil Tasken speaker news[2017-11-09) Director of NCMM, Professor Kjetil Taskén, has been appointed as the Head and Director of Institute for Cancer Research Oslo University Hospital (OUH). Professor Taskén will start his new position on 1 January 2018. Kjetil is the founding Director of NCMM, and until September 2017 also held the speaker position for the Nordic EMBL Partnership for Molecular Medicine. Since starting as the Director of the Biotechnology Centre of Oslo in 2003, and becoming Director of NCMM in 2008, he has overseen the growth, evolution and merging of the two organisations into the highly successful research centre that exists today.

Read more: NCMM Director to join Institute for Cancer Research at Oslo University

MIMS and UCMR PI:s receive funding from the Swedish Research Council

[2017-11-03] Several Researchers at MIMS and UCMR are among 40 people at Umeå University who will receive funding from The Swedish Research Council (VR). In total VR funded 569 application out of 2904 applications for both for Medicine and Health and for Natural and Engineering Sciences. The Swedish Research Council published its decision on the two calls on October 26th and October 31st on the research council’s website (www.vr.se).

Read more: MIMS and UCMR PI:s receive funding from the Swedish Research Council

Lessons from bacteria: Novel antimicrobial strategies based on interspecies metabolic cooperation

20171017 Aliashkevich Cava Alvarez 562 2MIMS- scientist publish in the high-impact Journal of the International Society for Microbial Ecology, ISME.

An important survival strategy in bacteria is the release of toxic substances, which can attack and kill cells and other bacteria. One of these substances are D-amino acids, which are secreted to the environment at high concentrations by very diverse bacteria. D-amino acids interfere with the growth of neighboring competitors thereby improving the chances of producer species to colonize an specific niche. Felipe Cava's research group at The Laboratory for Molecular Infection Medicine Sweden (MIMS) studied the biological effects caused by distinct D-amino acids released by the causative agent of cholera, Vibrio cholerae. The study was performed in collaboration with Miguel A de Pedro, a former visiting professor at Umeå University and investigator at the Centro de Biología Molecular ‘Severo Ochoa’, CSIC in Madrid, Spain.

The scientists found that D-Arginine is a very potent and very broad growth inhibitor of many diverse bacterial species, including pathogenic ones such as Burkholderias, well known for their implication in pulmonary infections and their broad antibiotic resistance.

Read more: Lessons from bacteria: Novel antimicrobial strategies based on interspecies metabolic cooperation

Anna Överby Wernstedt receives Hagberg prize

Overby[171015] Karolinska Institutet informed today that the Ebba-Christina Hagberg Foundation decided to award Anna Överby Wernstedt with the foundation's award for 2017 for her biochemical studies of viral infections.
According to Sven and Ebba-Christina Hagberg Foundation's motivation, Anna Överby Wernstedt receives the award for "her biochemical studies of viral infections. Her work is fundamental for our understanding of how the body defends itself against invading viruses."
"It's wonderful to get this prize and I feel deeply honoured", says Anna Överby Wernstedt. "The prize is a welcome additional funding of my research"

Read more: Anna Överby Wernstedt receives Hagberg prize

Emmanuelle Charpentier is one of the Albany Prize Awardees of 2017

Albany Prize EC[2017-09-27] The Albany Medical College awarded today during an awards ceremony in Albany, N.Y., Emmanuelle Charpentier together with Jennifer Doudna, Luciano Marraffini, Francisco J.M. Mojica, and Feng Zhang with the "America's most distinguished prize in medicine", as the Albany Medical College says on its website.

Read the news on the webpage of the Albany Medical College

Membrane vesicles released by bacteria may play different roles during infection - MIMS PhD defence Svitlana Vdovikova

Membrane Vesicle Akemi Takade Kyushu University Japan[2017-09-22] Bacteria release membrane-derived vesicles (MVs), which are small particles that can transport virulence factors to neighbouring bacteria or to the cells of a mammalian host. This special MV-based system for delivering toxic proteins and nucleic acids in a protected manner to the target cells may have different specific functions depending on whether the bacterium acts as an extracellular or intracellular pathogen. This is according to a doctoral thesis from MIMS-PhD studen Svitlana Vdovikova, Umeå University.

Read more: Membrane vesicles released by bacteria may play different roles during infection - MIMS PhD...

New Speaker announced for the Nordic EMBL Partnership

EMBL logo rgb webProfessor Bernt Eric Uhlin, Director of MIMS, will replace Professor Kjetil Taskén, Director of NCMM. The Nordic EMBL Partnership for Molecular Medicine is delighted to announce that Professor Bernt Eric Uhlin has been named as the Partnership’s new Speaker.

[20170919] Professor Uhlin is the Director of Molecular Infection Medicine Sweden (MIMS), and is also a professor at the Department of Molecular Biology at Umeå University. He was elected by the Partnership’s Steering Committee at the 8th annual Nordic EMBL Partnership meeting, hosted by the Institute for Molecular Medicine Finland (FIMM) in Helsinki in September 2017.

Read more: New Speaker announced for the Nordic EMBL Partnership

footer all slides 2014-02-06


Copyright © 2017 by The Laboratory for Molecular Infection Medicine Sweden (MIMS). All rights reserved.